Clinical trial
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
NCT00318110 · Center for International Blood and Marrow Transplant Research, Other · Terminated
Key facts
| NCT number | NCT00318110 |
|---|---|
| Title | Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma |
| Official title | Multicenter Phase II Study of Non-Myeloablative Allogeneic Stem Cell Transplantation Using Matched Unrelated Donor for Metastatic Renal Cell Carcinoma |
| Lead sponsor | Center for International Blood and Marrow Transplant Research, Other |
| Collaborators | M.D. Anderson Cancer Center |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Renal Cell Carcinoma |
| Intervention type | Procedure |
| Interventions | NST using MUD for metastatic renal cell carcinoma |
| Enrollment | 4 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 26, 2006 |
| Last update posted | Jul 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: